Neutral Versus Liberal fLuId In Traumatic Brain Injury: a Randomised Controlled Trial

Traumatic Brain Injury Clinical Trial

— LIMIT  

Official title:

The Effect of Neutral Versus Liberal fLuId Balance In TraumaTic Brain Injury: a Randomised Phase II Feasibility Controlled Trial

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT05983549
• Other study ID #: 001
• Status: Not yet recruiting
• Phase: N/A
• Start date: September 1, 2023
• Est. completion date: September 1, 2025

Study information

• Verified date: August 2023
• Source: Universita degli Studi di Genova
• Contact: Chiara Robba, PhD
• Phone: 3473912338
• Email: kiarobba[@]gmail.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Feasibility and safety of targeting neutral vs liberal fluid balance in traumatic brain injured patients: a phase II randomized controlled trial

Description:

To determine whether a zero fluid balance strategy during the first week compared to a more liberal fluid policy (allowing positive balance) is feasible in adult intensive care unit (ICU) patients with traumatic brain injury (TBI).Participants randomized to neutral fluid balance will be assessed daily with the aim to maintain a mean daily fluid balance of 0 over the course of the first 5 days from randomization (maximum at day 7 of ICU stay). In case of need for augmentation of cerebral perfusion pressure with 0 balance, fluids will be allowed according to a predefined protocol (see further).Participants randomized to the control group will receive the standard fluid management required as determined by the treating team. Fluid strategy as randomised should be applied for at least 5 days from randomization. Primary aim: ● Feasibility: ability to achieve a daily neutral balance (0 +/- 500 ml) in the intervention group. Secondary aims:● Incidence of renal complications, including acute kidney injury, need for renal replacement, multiorgan failure - Respiratory complications including reduced partial pressure of oxygen/ fraction of inspired oxygen (P/F) ratio - Cardiopulmonary complications, i.e myocardial infarction, cardiac failure, cardiac arrhythmias, ventricular or supraventricular, pulmonary oedema, ventilator associated pneumonia, acute respiratory distress syndrome - Difference in mean and daily CPP among the groups - Difference in daily fluid balance and fluid input during the first 7 days after ICU admission - Total and daily dose of vasopressors and diuretics during ICU stay - Vasopressor-free days up to 28 days from ICU admission - ICU-free days up to 28 days - Ventilator-free days up to 28 days from intubation. - Maximum Therapy intensity level (TIL) during the 5 days of randomization

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 80
• Est. completion date: September 1, 2025
• Est. primary completion date: May 1, 2025
• Accepts healthy volunteers: No
• Gender: All
• Age group: 16 Years and older

Eligibility

Inclusion Criteria:

• Adult patients with TBI (isolated or with extracranial injuries, with and without ICP monitoring)
• Admitted to intensive care unit
• Age >18 years
• Enrolment <48h after ICU admission

Exclusion Criteria:

• Enrolled in another clinical trial that is unapproved for co-enrolment
• Pregnant or suspected pregnancy
• Concomitant hemorrhagic shock expected to require surgical treatment in the following 24h from inclusion or requiring polytransfusions (> 6 blood products or massive transfusion protocol)
• Hemodynamic instability (HR > 120 despite fluid resuscitation of at least 1 liter, and systolic blood pressure < 90 mmHg) at the ICU admission requiring high dosage of norepinephrine (> 0.5 mcg/kg/min) or inotropes (any dose)

Related Conditions & MeSH terms

• Brain Injuries
• Brain Injuries, Traumatic
• Fluid Overload
• Outcome, Fatal
• Traumatic Brain Injury
• Wounds and Injuries

Intervention

Procedure:
• fluid balance
patients will receive fluids with the aim to achieve a neutral balance

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Universita degli Studi di Genova

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Feasibility- rate of patients able to achieve neutral fluid balance( 0 +/- 500 ml) during the first week from ICU admission	Ability to target and achieve a daily and total neutral fluid balance (0 +/- 500 ml) in the intervention group. In particular,testing the hypothesis of whether all pairwise differences between group means are the same in a design of repeated measures with 7 days points. We hypothesise a mean of 0 ml in the conservative group, a mean of 1000 ml in the liberal group and standard deviation in the population of 850 ml (500 ml in the conservative group and 1000 ml in the liberal group)	7 days
Secondary	Safety to achieve neutral balance, i.e. the estimation of the difference of incidence of renal, pulmonary, cardiac complications between the two arms	Complications occurring during the ICU stay	From date of randomization until the date of intensive care unit discharge or death assessed up to 6 months
Secondary	Rates of patients who die and experience poor neurological outcome after 6 months from ICU admission	at 6 months, at hospital and ICU discharge	6 months from ICU admission and enrolment